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Abstract
Objectives: Quercetin is a flavonoid and an important 
dietary constituent of fruits and vegetables. In recent 
years, several pharmacological activities of quercetin, 
such as its neuroprotective activity and, more spe-
cifically, its anti-convulsant effects in animal models 
of epilepsy, have been reported. This study evaluated 
the role of quercetin pretreatment on gene expression 
of γ-amino butyric acid type A (GABAA) receptor beta 
subunits in kainic acid (KA)-induced seizures in mice. 
Methods: The animals were divided into four groups: 
one saline group, one group in which seizures were 
induced by using KA (10 mg/kg) without quercetin 
pretreatment and two groups pretreated with querce-
tin (50 and 100 mg/kg) prior to seizures being induced 
by using KA. Next, the messenger ribonucleic acid 
(mRNA) levels of the GABAA receptor β subunits in the 
hippocampus of each animal were assessed at 2 hours 
and 7 days after KA administration. Quantitative re-
al-time polymerase chain reaction (RT-PCR) assay was 
used to detect mRNA content in hippocampal tissues.
Results: Pretreatments with quercetin at doses of 50 
and 100 mg/kg prevented significant increases in the 
mRNA levels of the β1 and the β3 subunits of the GAB-
AA receptor at 2 hours after KA injection. Pretreatment 
with quercetin (100 mg/kg) significantly inhibited β1 
and β3 gene expression in the hippocampus at 7 days 
after KA injection. But, this inhibitory effect of querce-
tin at 50 mg/kg on the mRNA levels of the β3 subunit of 
the GABAA receptor was not observed at 7 days after 
KA administration.
Conclusion: These results suggest that quercetin (100 
mg/kg) modulates the expression of the GABAA recep-
tor β1 and β3 subunits in the KA model of epilepsy, most 
likely to prevent compensatory responses. This may be 
related to the narrow therapeutic dose range for the 
anticonvulsant activities of quercetin. 
1. Introduction
Systemic administration of kainic acid (KA) induces 
seizures and brain damage associated with epilepsy 
[1]. γ-amino butyric acid (GABA) is the main inhibi-
tory neurotransmitter in the mammalian brain, and 
it is composed of five subunits that form a chloride 
channel. The messenger ribonucleic acid (mRNA) 
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molecules of the three β subunits have been shown to 
be distributed throughout the principal cell layers of the 
hippocampal and the parahippocampal areas in rats [2]. 
In addition, an association between mutations in the GA-
BRB3 gene, encoding the β3 subunit of the GABA receptor 
(GABR), and families from Honduras and Mexico with no 
incidents of childhood epilepsy has been established [3]. 
The association between mutations in the GABRB3 gene, 
encoding the β3 subunit of the GABAR, has been estab-
lished in families with childhood absence epilepsy (CAE) 
from Honduras and Mexico [3].
 Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonoid 
and an important dietary constituent of fruits and vegeta-
bles [4]. It has several biological effects [5], including an-
ti-oxidative [6] anti-inflammatory [7], and neuroprotective 
[8-10] activities. Quercetin at a concentration of 30 μM has 
been shown to have an inhibitory effect on the α1β1γ2 GAB-
AA and the p1 GABAc receptors in Xenopus laevis oocytes 
[11]. GABAAAp receptors are known to have low affinity for 
allosteric modulators of GABA such as benzodiazepine 
and barbiturates, and quercetin has been shown to antag-
onize GABAAAp1 receptors in a dose-dependent way via a 
redox-independent allosteric mechanism [12]. 
Our previous studies demonstrated that quercetin had 
an anticonvulsant activity in acute and chronic models of 
pentylenetetrazole (PTZ) in rats [13, 14]. Furhtermor, the 
expressions of the GABAA receptor β subunits were report-
ed to have been altered at early time points during or soon 
after acute seizures induced by KA injection, [15]. Thus, 
this study aimed to assess the effects of quercetin by deter-
mining the variations in the mRNA levels in the β subunits 
of GABAA receptors in the KA model of epilepsy in mice.
2.  Materials and Methods
 A total of 70 male BALB/c mice (20 ─ 25 g) were main-
tained at constant room temperature (21°C ± 2°C) under a 
12:12 hour light/dark cycle and had free access to food and 
water. All animal experiments were performed in accord-
ance with the European Communities Council Directive of 
November 24, 1986 (86/609/EEC).
 The 70 mice were divided into 4 groups as follows: Each 
mouse in the saline group (group 1, n = 10) received a dai-
ly intraperitoneal (i.p.) injection of saline and Tween 80 
(10 mL/kg) for 6 days and two i.p. injections of saline 30 
minutes apart on the 7th day. Each mouse in the KA group 
(group 2, n = 20) received a daily i.p. injection of saline for 
6 days and an i.p. injection of saline 30 minutes prior to the 
i.p. injection of KA (10 mg/kg) on the 7th day. The mice in 
groups 3 (n = 20) and 4 (n = 20) received daily i.p. injections 
with quercetin at doses of 50 and 100 mg/kg, respectively, 
for 6 days and, on the 7th day i.p. injections of  KA (10 mg/
kg, i.p.) were administered 30 minutes after the quercetin 
injections. Fifty percent of mice in each group were anes-
thetized with i.p. injections of ketamine (60 mg/mL)/xy-
lazine (6 mg/kg), and then sacrificed at 2 hours after KA 
administration, with the other fifty percent undergoing the 
same procedure at 7 days after KA administration. 
  The β-actin gene was used as an internal control for quan-
tifying the expressions of the target genes. Primers for the 
Gabrb1 and the Gabrb3 genes of subunits of the GABAA 
receptors were designed by using Gene Runner software 
(version 3.05). Primer sets were Gabrb1 F: 5´CCTGGCTC-
TACTGGAATATG3´, R: 5´ATTGGCACTCTGGTCTTG3´; 
Gabrb3 F: 5´CTCCTACGCTGGTGTCTGAA3´, R: 5´CACT-
GTGTTCCCACATGACA3´; β-actin F: TTACTGAGCTG-
CGTTTTACAC, R: ACAAAGCCATGCCAATGTTG.
 Quantitative real-time polymerase chain reaction (RT-
PCR) assays were conducted with SYBR Green I Master 
Mix (Bioneer, Korea). Thermal cycling was performed us-
ing the ABI-7500 Sequence Detection System (Applied Bi-
osystems, Foster, CA, USA) as follows: 10 minutes at 95°C 
for the first denaturation step, followed by 40 cycles at 95°C 
for a total of 20 seconds and 40 cycles at 60°C for a total 
of 45 seconds. The values of the cycle threshold (Ct) were 
used to quantify mRNA fold changes. In this regards, we 
used the 2−ΔΔCt calculating method by normalizing the Ct 
of the target mRNAs to the Ct of housekeeping gene β-actin 
in the treated and the control samples.
 Data were expressed as means ± standard errors of the 
mean (SEMs). Statistical analyses were performed using 
the one-way analysis of variance (ANOVA), followed by 
the post-hoc Turkey test for multiple comparisons. For the 
analyses, Prism software was used. P < 0.05 was consid-
ered statistically significant.
3. Results
Compared to the mRNA levels of the GABAA receptor β1 
subunit in the saline group, those levels in the KA group 
were significantly increased in the hippocampi of the mice 
at 2 hours and 7 days after KA administration (Figs. 1A, 
1B). In contrast, no statistically significant changes were 
observed in the quercetin groups compared to the saline 
at those times. However, statistically significant differences 
were observed when comparing the KA group and the 100-
mg/kg quercetin group at 7 days after KA administration.
The mRNA levels of the GABAA receptor β3 subunit were 
significantly higher in the KA group at 2 hours and 7 days 
after KA administration than they were in the saline group 
(Figs. 2A, 2B). In contrast, no significant differences were 
observed in the mRNA levels of the GABAA receptor β3 sub-
unit between the 50-mg/kg quercetin group at 2 hours af-
ter KA administration and the saline group (Fig. 2A). How-
ever, mRNA levels were increased in the quercetin 50-mg/
kg group at 7 days after KA administration compared to the 
saline group (Fig. 2B).
Furthermore, the mRNA levels of the GABAA receptor β3 
subunit observed in the 100-mg/kg quercetin group at 2 
hours and 7 days after KA administration were similar to 
those observed in the saline group at those times (Figs. 
2A, 2B). However, significant differences were found when 
comparing the KA group and both quercetin groups at 2 
hours after KA administration (Fig. 2A). Moreover, signifi-
cant differences were observed between the KA group and 
the quercetin groups at 7 days after KA administration (Fig. 
2B).
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4. Discussion
This study aimed at determining the effects of quercetin 
pretreatment on the expressions of the β1 and the β3 sub-
units of the GABAA receptor in a mouse KA-induced sei-
zure model. The doses of quercetin used in this study were 
the same as those employed in a previous study assessing 
quercetin’s anticonvulsant activity [13, 14]. Compared to 
the saline group, pretreatments with quercetin at doses of 
50 and 100 mg/kg prevented significant increases in the 
mRNA levels of the β1 and the β3 subunits of the GABAA re-
ceptor at 2 hours after KA injection. In addition, pretreat-
ment with 100 mg/kg of quercetin inhibited increases in 
the mRNA levels of the β3 subunit of the GABAA receptor at 
7 days after KA administration. Our results showed similar 
mRNA levels of the β1 and the β3 subunits of the GABAA 
receptor both in the 100-mg/kg quercetin group at 2 hours 
and day 7 after KA administration and the saline group, 
suggesting that high doses of quercetin have inhibitory ef-
fects on the gene expression in the β1 and the β3 subunits 
of the GABAA receptor. However, this inhibitory effect of 
quercetin at 50 mg/kg on the mRNA levels of the β3 sub-
unit of the GABAA receptor was not observed at 7 days af-
ter KA administration. This may be related to the narrow 
therapeutic dose range for the anticonvulsant activities of 
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Figure 1 Effect of quercetin on the mRNA ratio of the expression of the β1 subunit of the GABAA receptor in KA-induced seizure in mice at (A) 2 
and (B) 7 hours after KA administration. 
*P < 0.01 compared to the saline, †P < 0.001 compared to the KA group at D7, n = 10.
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mRNA, messenger ribonucleic acid; GABAA, γ-amino butyric acid type A; KA, kainic acid.
Figure 2 Effect of quercetin on the mRNA ratio of expression of the β3 subunit of the GABAA receptor in the KA model in mice at (A) 2 and (B) 7 
hours after KA administration. †P < 0.001 compared to the KA at 2 hours, *P < 0.01 compared to the KA group at 2 hours, ‡P < 0.001 compared to 
the saline at 2 hours, *P < 0.01 compared to the  saline at D7, n = 10, ‡P < 0.001 compared to the KA group at D7, †P < 0.001 compared to the saline 
and P < 0.05 compared to the KA group at D7, n = 10.
mRNA, messenger ribonucleic acid; GABAA, γ-amino butyric acid type A; KA, kainic acid.
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quercetin in different modes of seizure.
Of the three β subunits of the GABAA receptor, the mRNA 
level in the β3 subunit is the one that is increased in ani-
mal models and human temporal lobe epilepsy (TLE), as 
well as in the KA-induced-seizure model [16]. In addition, 
significant increases in the mRNA levels in the β1 and the 
β3 subunits have been observed in the granule cells of the 
dentate gyrus at 12 hours to 30 days and at 7 to 30 days after 
KA injection. These changes are consistent with the pre-
sumed compensatory up-regulation of GABAA receptors 
observed in the dentate molecular layer in epileptic rats 
[17]. 
5. Conclusion
 In conclusion, pretreatment with quercetin significant-
ly inhibited the gene expression of the GABAA receptor β 
subunits in the KA model of seizure. Quercetin (100 mg/
kg) seems to modulate the expression of the GABAA recep-
tor β subunits to prevent any progress in neurodegenera-
tive and compensatory responses.
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